TrialMolecular oncology2022

Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.

Renaud Sabatier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.